Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 3, 2003, Pages 755-763

  Taylor, N ^a   Kelly, J F ^a   Kuban, D A ^a   Babaian, R J ^a   Pisters, L L ^a   Pollack, A ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; REGRESSION ANALYSIS; TUMORS;

BIOCHEMICAL CONTROL;

RADIOTHERAPY;

ANDROGEN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BIOCHEMISTRY; CANCER DIAGNOSIS; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; FOLLOW UP; GAMMA RADIATION; HAZARD; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; REGRESSION ANALYSIS; RISK FACTOR; SALVAGE THERAPY; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037605970     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00069-5     Document Type: Article

References (40)

1. Valicenti R.K., Gomella L.G., Ismail M., et al. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer A matched-pair analysis . Int J Radiat Oncol Biol Phys. 45:1999;53-58.
2. Leibovich B.C., Engen D.E., Patterson D.E., et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol. 163:2000;1178-1182.
3. Petrovich Z., Lieskovsky G., Stein J.P., et al. Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer. BJU Int. 89:2002;604-611.
4. Grossfeld G.D., Tigrani V.S., Nudell D., et al. Management of a positive surgical margin after radical prostatectomy Decision analysis . J Urol. 164:2000;93-100.
5. Kupelian P.A., Katcher J., Levin H.S., et al. Stage T1-2 prostate cancer A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy . Int J Radiat Oncol Biol Phys. 37:1997;1043-1052.
6. Epstein J.I., Partin A.W., Sauvageot J., et al. Prediction of progression following radical prostatectomy A multivariate analysis of 721 men with long-term follow-up . Am J Surg Pathol. 20:1996;286-292.
7. Anscher M.S., Prosnitz L.R. Multivariate analysis of factors predicting local relapse after radical prostatectomy - Possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 21:1991;941-947.
8. Zeitman A.L., Coen J.J., Shipley W.U., et al. Radical radiation therapy in the management of prostatic adenocarcinoma The initial prostate specific antigen value as a predictor of treatment outcome . J Urol. 151:1994;640-645.
9. Paulson D.F. Impact of radical prostatectomy in the management of clinically localized disease. J Urol. 152:1994;1826-1830.
10. Schild S.E. Radiation therapy (RT) after prostatectomy The case for salvage therapy as opposed to adjuvant therapy . Int J Cancer. 96:2001;94-98.
11. Forman J.D., Velasco J. Therapeutic radiation in patients with a rising post-prostatectomy PSA level. Oncology (Huntingt). 12:1998;33-47.
12. Pollack A., Smith L. Adjuvant external beam radiation therapy postprostatectomy. 2002;Lippincott Williams & Wilkins, Philadelphia.
13. Anscher M.S. Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen. Int J Cancer. 96:2001;91-93.
14. Catton C., Gospodarowicz M., Warde P., et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol. 59:2001;51-60.
15. Vicini F.A., Ziaja E.L., Kestin L.L., et al. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology. 54:1999;111-117.
16. Zelefsky M.J., Aschkenasy E., Kelsen S., et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 39:1997;327-333.
17. Pisansky T.M., Kozelsky T.F., Myers R.P., et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. J Urol. 163:2000;845-850.
18. Nudell D.M., Grossfeld G.D., Weinberg V.K., et al. Radiotherapy after radical prostatectomy Treatment outcomes and failure patterns . Urology. 54:1999;1049-1057.
19. Garg M.K., Tekyi-Mensah S., Bolton S., et al. Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy. Urology. 51:1998;998-1002.
20. Anscher M.S. Adjuvant therapy for pathologic stage C prostate cancer A casualty of the PSA revolution? Int J Radiat Oncol Biol Phys. 34:1996;745-747.
21. Zagars G.K., von Eschenbach A.C., Ayala A.G., et al. The influence of local control on metastatic dissemination of prostate cancer treated by external beam megavoltage radiation therapy. Cancer. 68:1991;2370-2377.
22. Pound C., Partin A., Eisenberger M., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597.
23. Pound C.R., Partin A.W., Epstein J.I., et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am. 24:1997;395-406.
24. Blute M.L., Bergstralh E.J., Partin A.W., et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol. 164:2000;1591-1595.
25. Centeno B., Zietman A., Shipley S., et al. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 30:1994;309-315.
26. Anscher M.S., Prosnitz L.R. Multivariate analysis of factors predicting local relapse after radical prostatectomy - Possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 21:1991;941-947.
27. Valicenti R.K., Gomella L.G., Ismail M., et al. Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma Effect of early adjuvant radiation therapy on biochemical control . Cancer. 82:1998;1909-1914.
28. Cox J., Gallagher M., Hammond E., et al. Consensus statements on radiation therapy of prostate cancer Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels and radical prostatectomy . J Clin Oncol. 17:1999;1155.
29. Anscher M.S., Clough R., Dodge R. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy The first 10 years . Int J Radiat Oncol Biol Phys. 48:2000;369-375.
30. Zelefsky M., Hollister T., Raben A., et al. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 47:2000;1261-1266.
31. Chawla A.K., Thakral H.K., Zietman A.L., et al. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma Analysis of efficacy and prognostic factors . Urology. 59:2002;726-731.
32. Wilder R.B., Hsiang J.Y., Ji M., et al. Preliminary results of three-dimensional conformal radiotherapy as salvage treatment for a rising prostate-specific antigen level postprostatectomy. Am J Clin Oncol. 23:2000;176-180.
33. Morris M.M., Dallow K.C., Zietman A.L., et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 38:1997;731-736.
34. Valicenti R.K., Gomella L.G., Ismail M., et al. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer The importance of radiation dose . Urology. 52:1998;1034-1040.
35. Crane C.H., Rich T.A., Read P.W., et al. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. Int J Radiat Oncol Biol Phys. 39:1997;681-686.
36. Wu J.J., King S.C., Montana G.S., et al. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen. Int J Radiat Oncol Biol Phys. 32:1995;317-323.
37. Eulau S.M., Tate D.J., Stamey T.A., et al. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer. Int J Radiat Oncol Biol Phys. 41:1998;735-740.
38. Valicenti R.K., Gomella L.G., Ismail M., et al. Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 42:1998;501-506.
39. McGowan D.G. Radiation therapy in the management of localized carcinoma of the prostate A preliminary report . Cancer. 39:1977;98-103.
40. Mayer R., Pummer K., Quehenberger F., et al. Postprostatectomy radiotherapy for high-risk prostate cancer. Urology. 59:2002;732-739.